Squarepoint Ops LLC Oncocyte Corp Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $24,773 - $48,469	-21,542 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $118,089 - $207,814	-57,887 Reduced 72.88%	21,542 $47,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $36,380 - $60,702	10,306 Added 14.91%	79,429 $283,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $6.0 $49,590 - $78,924	-13,154 Reduced 15.99%	69,123 $397,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $196,642 - $534,800	82,277 New	82,277 $427,000
Q3 2020 Nov 16, 2020	SELL	$1.2 - $1.89 $25,652 - $40,402	-21,377 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $20,244 - $36,566	10,599 Added 98.34%	21,377 $41,000
Q1 2020 May 15, 2020	BUY	$1.76 - $3.02 $18,969 - $32,549	10,778 New	10,778 $26,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.